Curative Shares Pandemic Response at the Nextflow Summit for Bioinformatics
1 Minute
Team Curative
Oct 20, 2022
Curative’s rapid and widespread response to the COVID-19 pandemic has enabled us to develop novel solutions to longstanding issues in the health industry. To date, Curative has resulted over 30 million tests and has determined the viral variant of over 33,000 COVID-19 genomes across the United States.
In October 2022, Curative team member Tony Zeljkovic presented on our work scaling testing solutions, building bioinformatics infrastructure, and increasing lab capacity throughout the pandemic at the Nextflow Summit in Barcelona.
The Nextflow Summit is an international bioinformatics conference that brings together industry leaders to showcase their work and innovation. We are honored to have been in the company of so many leaders and to share our story.
Watch our presentation to learn more about Curative’s bioinformatics and COVID-19 work.